Project Grant HT94252310279
Award Date
6/1/23
Completion Date
5/31/26
Dollars Obligated
$550K
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Iowa City, IA 52242, USA
Similar Awards
The University of Iowa was awarded a $311,000 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420) to conduct research on identifying the temporal and spatial origins and reversibility of neurodevelopmental disorders with autism in mouse models. The grant, awarded on June 1, 2024, will fund this research project through May 31, 2026. The Military Medical Research and Development program supports biomedical...
The University of California, San Diego will research the mechanisms of heterogeneous neural expression of autism spectrum disorder under a three-year, $868,542 Project Grant from the Department of the Army Medical Command. The grant is part of the Military Medical Research and Development program administered by the agency under Assistance Listing Number 12.420. This program supports biomedical research that transforms military and public health care through innovative solutions for battlefield...
The University of Iowa received a $816,178 Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The grant, titled "TARGETED THERAPY FOR MPNST METASTASIS," will support research activities at the University of Iowa from June 1, 2024 to May 31, 2027. The research aims to develop innovative treatments for metastatic malignant peripheral nerve sheath tumors, a rare and aggressive type of cancer. This federal grant...
The University of Iowa was awarded a $777,500.00 Project Grant from the Defense Health Agency to conduct research under the Military Medical Research and Development (CFDA 12.420) program. The grant, awarded on August 1, 2023, will fund a 3-year project to identify genetic mechanisms driving the transition of benign nevi to malignant melanoma. As a leading public research university, the University of Iowa has extensive experience delivering high-quality biomedical research, healthcare services,...
The Defense Health Agency awarded a $863,500 Project Grant to Rutgers, The State University of New Jersey under the Military Medical Research and Development federal grant program (CFDA 12.420). The three-year award beginning September 1, 2022 will support research into "Genetically Distinct ASD Subtypes: Is MTOR Dysregulation a Common Mechanism?" Through this funding, Rutgers researchers will investigate potential connections between mutations in the MTOR gene pathway and autism...
The Department of Defense's Military Medical Research and Development program (CFDA 12.420) has awarded a $748,815 Project Grant to the University of Iowa. The grant, awarded on July 1, 2024, will support the "Women's Health in Tuberous Sclerosis Complex: A Population-Based Assessment of Morbidity to Inform Clinical Care" project. This research aims to provide a comprehensive assessment of the health issues faced by women with tuberous sclerosis complex, a rare genetic disorder, in...
The University of Iowa was awarded a $1.3 million Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development program. The three-year award will support preclinical development of use-dependent selective blockers of GluA2-lacking AMPA receptors to prevent noise-induced neurodegeneration. The goal is to investigate medical solutions for the battlefield by transforming health care for service members and the public through innovative biomedical...
This Project Grant award in the amount of $816,375.00 was provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to The University of Iowa. The grant funds a research project titled "MECHANISMS OF NEURONAL DYSREGULATION UNDERLYING BEHAVIORAL ALTERATIONS IN NEUROFIBROMATOSIS TYPE 1" with a performance period from July 1, 2024 to June 30, 2027. This research aims to investigate the neurological mechanisms underlying behavioral...
The Department of Defense's Military Medical Research and Development program (CFDA 12.420) has awarded Scripps Research Institute, a nonprofit biomedical research organization, a $529,125 project grant to investigate microglia dysfunction in MEF2C deficiency autism spectrum disorder with the goal of discovering targeted therapies. This 3-year award, effective September 30, 2024, will fund research aimed at improving the health and care of military service members, veterans, and their families...
The University of Iowa was awarded a $1,529,022 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420). The three-year award will fund research from February 2021 to February 2024 to investigate SUMO inhibition and its ability to repress mammary oncogenesis through the ETV1 protein. The Military Medical Research and Development program aims to transform military and public health through innovative biomedical...